Latest filing published 06 Jan 2021 for ENDRA Life Sciences Inc., €73.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -27.5%Entry US$35,350.00 · Close at T+365 US$25,620.00
- -46.1%Entry US$54,600.00 · Close at T+365 US$29,435.00
- +15.7%Entry 0.04 · Close at T+365 0.05
- -10.8%Entry 0.05 · Close at T+365 0.05
- -13.3%Entry 0.05 · Close at T+365 0.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David R. Wells: trading record in brief
David R. Wells discloses dealings in 2 companies, chiefly Sionix Corp and ENDRA Life Sciences Inc. We count 25 filings; the first trade dates from 29 March 2010 and the latest from 6 January 2021.
The open-market side counts 11 purchases for €43k alongside 2 sales for €26k. On balance, insiders were net buyers of €18k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants. Since January 2021: no purchases and 2 sales on the market.
A typical purchase (the median) is worth €770. No cluster: in 3 purchases, no other insider of the company bought within 30 days. Ninety days after publication, 9 purchases show a median change of -2.0%, with the price up in 22% of them. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 6 January 2021: an open-market sale of €73, in ENDRA Life Sciences Inc. The clock since the last published purchase (30 September 2019) now reads 2,596 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David R. Wells
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$0.900.1% of flowCommon StockSEC:0001209191-21-002370:0
- 34,900 shares@ US$0.9035.9% of flowCommon StockSEC:0001209191-21-002370:1
- 5,000 shares@ US$0.8717.0% of flowCommon StockSEC:0001209191-20-038681:0
- 10,350 shares@ US$0.8735.2% of flowCommon StockSEC:0001209191-20-035438:0
- 79,653 shares0Common StockSEC:0001209191-20-024213:0
- 10,000 shares@ US$1.1823.7% of flowCommon StockSEC:0001209191-19-051091:0Canonical exit: 26 Dec 2019 (T+90)
- 5,000 shares@ US$1.5615.5% of flowCommon StockSEC:0001209191-19-047405:0Canonical exit: 20 Nov 2019 (T+90)
- 5,000 shares@ US$1.5515.4% of flowCommon StockSEC:0001209191-19-047405:1Canonical exit: 21 Nov 2019 (T+90)
- 5,953 shares@ US$1.6819.5% of flowCommon StockSEC:0001209191-18-058723:0
- 18,833 shares0Common StockSEC:0001209191-17-032899:0
- 2,250,000 shares0Common StockSEC:0001354488-12-002179:0
- 20,833 shares@ US$0.048Common StockSEC:0001354488-12-002159:0
- 509,804 shares@ US$0.051Common StockSEC:0001354488-12-002166:0
- 2,000,000 shares@ US$0.04Common StockSEC:0001354488-12-002166:1
- 4,250,000 shares0Common StockSEC:0001354488-12-002166:2
- 20,833 shares@ US$0.048Common StockSEC:0001354488-11-000011:0Canonical exit: 3 Apr 2011 (T+90)
- 22,222 shares@ US$0.045Common StockSEC:0001354488-10-003903:0Canonical exit: 15 Mar 2011 (T+90)
- 16,666 shares@ US$0.06Common StockSEC:0001354488-10-003855:0Canonical exit: 1 Mar 2011 (T+90)
- 15,386 shares@ US$0.065Common StockSEC:0001354488-10-003854:0Canonical exit: 13 Feb 2011 (T+90)
- 25,000 shares0Common StockSEC:0001354488-10-003853:0
- 25,000 shares0Common StockSEC:0001354488-10-003348:0
- 18,181 shares@ US$0.548Common StockSEC:0001354488-10-003348:1Canonical exit: 13 Jan 2011 (T+90)
- 17,181 shares@ US$0.0579Common StockSEC:0001354488-10-003348:2Canonical exit: 30 Jan 2011 (T+90)
23 of 23 declarations
